Progression of diabetic nephropathy

Slides:

Advertisements

Similar presentations

Improved prognosis of diabetic nephropathy in type 1 diabetes

Advertisements

Volume 55, Issue 2, Pages (February 1999)

Plasma sodium and hypertension

Frederik Persson, Peter Rossing Kidney International Supplements

Confounding: What it is and how to deal with it

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Summary of Recommendation Statements

High prevalence of chronic kidney disease in Thailand

Volume 67, Issue 6, Pages (June 2005)

The effect of hypertension on the risk for kidney cancer in Korean men

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes Robert W. Schrier, Raymond.

Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan

Prehypertension and chronic kidney disease: the ox or the plow?

Volume 80, Issue 10, Pages (November 2011)

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

John P. Middleton, Patrick H. Pun Kidney International

Volume 55, Issue 2, Pages (February 1999)

Volume 57, Pages S32-S37 (April 2000)

Anemia as a risk factor for chronic kidney disease

Volume 54, Issue 4, Pages (October 1998)

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 63, Issue 1, Pages (January 2003)

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Study of Heart and Renal Protection (SHARP)

Volume 65, Issue 6, Pages (June 2004)

Blood pressure targets in hemodialysis patients

Volume 73, Issue 9, Pages (May 2008)

Volume 85, Issue 3, Pages (March 2014)

Volume 67, Issue 1, Pages (January 2005)

The third World Kidney Day: Looking back and thinking forward

Volume 53, Issue 4, Pages (April 1998)

Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1 Peter Hovind, MD, Lise Tarnow, MD, Peter Rossing,

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 87, Issue 1, Pages (January 2015)

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

The kidney, a cardiovascular risk marker, and a new target for therapy

Volume 67, Issue 4, Pages (April 2005)

Volume 67, Pages S52-S54 (January 2005)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 74, Issue 5, Pages (September 2008)

Improved prognosis of diabetic nephropathy in type 1 diabetes

Volume 71, Issue 4, Pages (February 2007)

Volume 60, Issue 1, Pages (July 2001)

Circadian regulation of renal function

Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Michael R. Lattanzio, Matthew R. Weir Kidney International

Is it the low-protein diet or simply the salt restriction?

Volume 70, Issue 3, Pages (August 2006)

Is complement a target for therapy in renal disease?

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 56, Issue 4, Pages (October 1999)

Volume 68, Issue 3, Pages (September 2005)

Volume 58, Issue 2, Pages (August 2000)

Volume 55, Issue 3, Pages (March 1999)

Hisataka Kobayashi, Peter L. Choyke Kidney International

Volume 68, Issue 3, Pages (September 2005)

Volume 53, Issue 5, Pages (May 1998)

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Nauman Siddiqi, Maureen A. McBride,

Volume 57, Issue 2, Pages (October 2000)

Volume 79, Issue 10, Pages (May 2011)

Presentation transcript:

Progression of diabetic nephropathy Peter Hovind, Peter Rossing, Lise Tarnow, Ulla M. Smidt, Hans-Henrik Parving Kidney International Volume 59, Issue 2, Pages 702-709 (February 2001) DOI: 10.1046/j.1523-1755.2001.059002702.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Impact of mean arterial blood pressure, glycosylated hemoglobin A1c, albuminuria, and serum cholesterol on the decline in GFR (P < 0.001 for each factor). Kidney International 2001 59, 702-709DOI: (10.1046/j.1523-1755.2001.059002702.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 The decline in GFR divided according to median of mean arterial blood pressure combined with median albuminuria, glycosylated hemoglobin A1c, and serum cholesterol. Within each combination of risk factors, a comparison of the four different strata revealed a significant difference (P < 0.001). Kidney International 2001 59, 702-709DOI: (10.1046/j.1523-1755.2001.059002702.x) Copyright © 2001 International Society of Nephrology Terms and Conditions